ArticleBritish journal of pharmacology2022

The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis.

Miguel Carracedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.